The effect of co-colonization with community-acquired and hospital-acquired methicillin-resistant Staphylococcus aureus strains on competitive exclusion

Journal of Theoretical Biology

Volumn 264, Issue 3, 2010, Pages 645-656

  Pressley, Joanna ^a   D'Agata, Erika M C ^b   Webb, Glenn F ^a  

^a VANDERBILT UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Co existence; Co infection; Disease transmission; Population model; Two strain model

Indexed keywords

ANTIBIOTIC RESISTANCE; BACTERIAL DISEASE; COMPETITION (ECOLOGY); DISEASE TRANSMISSION; HOSPITAL SECTOR; POPULATION MODELING;

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; COMMUNICABLE DISEASE; CONTROLLED STUDY; ENDEMIC DISEASE; HOSPITAL INFECTION; HYGIENE; INFECTION CONTROL; MATHEMATICAL MODEL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MIXED INFECTION; PRIORITY JOURNAL; STRAIN DIFFERENCE;

COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; ENDEMIC DISEASES; HUMANS; INFECTION CONTROL; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MODELS, THEORETICAL; SPECIES SPECIFICITY; STAPHYLOCOCCAL INFECTIONS;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 77952603988     PISSN: 00225193     EISSN: 10958541     Source Type: Journal    
DOI: 10.1016/j.jtbi.2010.03.036     Document Type: Article

References (37)

1. Ackleh A.S., Allen L.J.S. Competitive exclusion and coexistence for pathogens in an epidemic model with variable population size. J. Math. Bio. 2003, 47:153-168.
2. Allen L.J.S., Langlais M., Phillips C.J. The dynamics of two viral infections in a single host population with applications to hantavirus. Math. Biosci. 2003, 186(2):191-217.
3. Baba T., Takeuchi F., Kuroda M., Yuzawa H., Aoki K., Oguchi A., Nagai Y., Iwama N., Asano K., Naimi T. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 2002, 359:1819-1827.
4. Bassetti M., Nicco E., Mikulska M. Why is community-associated MRSA spreading across the world and how will it change clinical practice?. Int. J. Antimicrobial Agents 2009, 34(S1):S15-S19.
5. Bhunu C.P., Garira W., Mukandavire Z. Modeling HIV/AIDS and tuberculosis coinfection. Bull. Math. Bio. 2009, 71(7):1745-1780.
6. Blyuss K.B., Kyrychko Y.N. On a basic model of a two-disease epidemic. Appl. Math. Comput. 2005, 160(1):177-187.
7. Castillo-Chavez C., Feng Z. To treat or not to treat: the case of tuberculosis. J. Math. Bio. 1997, 35(6):629-656.
8. Castillo-Chavez C., Huang W., Li J. Competitive exclusion and coexistence of multiple strains in an SIS STD model. SIAM J. Appl. Math. 1999, 59(5):1790-1811.
9. Cespedes C., Saïd-Salim B., Miller M., Lo S.H., Kreiswirth B.N., Gordon R.J., Vavagiakis P., Klein R.S., Lowy F.D. The clonality of Staphylococcus aureus nasal carriage. J. Infect. Dis. 2005, 191:444-452.
10. Cooper B.S., Medley G.F., Stone S.P., et al. Methicillin-resistant Staphylococcus aureus in hospitals and the community: stealth dynamics and control catastrophes. Proc. Natl. Acad. Sci. USA 2004, 101(27):247-263.
11. Crawford B., KribsZaleta C.M. The impact of vaccination and coinfection on HPV and cervical cancer. Discrete Continuous Dyn. Syst. Ser. B 2009, 12(2):279-304.
12. D'Agata E.M.C., Webb G.F., Horn M.A., Moellering R.C., Ruan S. Modeling the invasion of community-acquired methicillin-resistant Staphylococcus aureus into hospitals. Clin. Infect. Dis. 2009, 48(3):274-284.
13. Davis S.L., Rybak M.J., Amjad M., Kaatz G.W., McKinnon P.S. Characteristics of patients with healthcare-associated infection due of SCCmec type IV methcillin-resistant Staphylococcus aureus. Infect. Control Hosp. Epidemiol. 2006, 27:1025-1031.
14. Diekema D.J., Climo M. Preventing MRSA infections: finding it is not enough. JAMA 2008, 299:1190-1192.
15. Herold B.C., Immergluck L.C., Maranan L.C., Lauderdale D., Gaskin R., Boyle-Vavra S., Leitch C.D., Daum R.S. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 1998, 279(8):508-593.
16. Hethcote H.W. The mathematics of infectious diseases. SIAM Rev. 2000, 42(4):599-653.
17. Hidron A.I., Kourbatova E.V., Halvosa J.S., Terrell B.J., McDougal L.K., Tenover F.C., Blumberg H.M., King M.D. Risk factors for colonization with methicillin-resistant Staphylococcus aureus (MRSA) in patients admitted to an urban hospital: emergence of community-associated MRSA nasal carriage. Clin. Infect. Dis. 2005, 15:159-166.
18. Jarvis W.R., Schlosser J., Chinn R.Y., Tweeten S., Jackson M. National prevalence of methicillin-resistant Staphylococcus aureus in inpatients at US health care facilities. Am. J. Infect. Control 2007, 35:631-637.
19. Klevens R.M., Morrison M.A., Nadle J., Petit S., Gershman K., Ray S., Harrison L.H.M., Lynfield R., Dumyati G., Townes J.M., Craig A.S., Zell E.R., Fosheim G.E., McDougal L.K., Carey R.B., Fridkin S.K. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007, 298:1763-1771.
20. Korobeinikov A. Global properties of SIR and SEIR epidemic models with multiple parallel infectious stages. Bull. Math. Bio. 2009, 71(1):75-83.
21. Korobeinikov A., Wake G.C. Lyapunov functions and global stability for SIR, SIRS, and SIS epidemiological models. App. Math. Lett. 2002, 15:955-960.
22. Kuehnert M.J., Hill H.A., Kupronis B.A., Tokars J.I., Solomon S.L., Jernigan D.B. Methicillin-resistant Staphylococcus aureus hospitalizations. US Emerg. Infect. Dis. 2005, 11(9):868-872.
23. Lautenbach E., Tolomeo P., Black N., Maslow J. Risk factors for fecal colonization with multiple distinct strains of Escherichia coli among long-term care facility residents. Infect. Control Hosp. Epidemiol. 2009, 30:491-493.
24. Li J., Zhien M., Blythe S.P., Castillo-Chavez C. Coexistence of pathogens in sexually-transmitted disease models. J. Math. Biol. 2003, 47:547-568.
25. Martcheva M., Iannelli M., Li X. Subthreshold coexistence of strains: the impact of vaccination and mutation. Math. Biosci. Eng. 2007, 4(2):287-317.
26. Martcheva M., Pilyugin S.S. The role of coinfection in multi-disease dynamics. SIAM J. Appl. Math. 2006, 66(3):843-872.
27. Nuño M., Chowell G., Wang X., Castillo-Chavez C. On the role of cross-immunity and vaccines on the survival of less fit flu strains. Theor. Popul. Biol. 2007, 71(1):20-29.
28. Okuma K., Iwakawa K., Turnidge J.D., Grubb W.B., Bell J.M., O'Brien F.G., Coombs G.W., Pearman J.W., Tenover F.C., Kapi M., Tiensasitorn C., Ito T., Hiramatsu K. Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. J. Clin. Microbiol. 2002, 40:4289-4294.
29. Otter J.A., French G.L. Nosocomial transmission of community-associated methicillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect. Dis. 2006, 6(12):753-755.
30. Perko L. Differential Equations and Dynamical Systems 2001, Springer-Verlag, New York, NY, (Chapter 2).
31. Popovich K.J., Weinstein R.A., Hota B. Are community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains?. Infect. Control Hosp. Epidemiol. 2008, 46:795-798.
32. Qui, Z., Feng, Z., 2009. Transmission dynamics of an influenza model with vaccination and antiviral treatment. Bull. Math. Bio. June 30, Epub.
33. Saiman L., O'Keefe M., Graham P.L., Wu F., Saïd-Salim B., Kreiswirth B., LaSala A., Schlievert P.M., Della-Latta P. Hospital transmission of community-acquired methicillin-resistant Staphylococcus aureus among postpartum women. Clin. Infect. Dis. 2003, 37(10):1313-1319.
34. van den Driessche P., Watmough J. Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission. Math. Biosci. 2002, 180:29-48.
35. Webb G.F., Horn M.A., D'Agata E.M.C., Moellering R.C., Ruan S. Competition of hospital-acquired and community-acquired methicillin-resistant Staphylococcus aureus strains in hospitals. J. Biol. Dyn. 2010, 4(1):115-129.
36. Wertheim H.F., Verveer J., Boelens H.A., van Belkum A., Verbrugh H.A., Vos M.C. Effect of mupirocin treatment on nasal, pharyngeal, and perineal carriage of Staphylococcus aureus in healthy adults. Antimicrob. Agents Chemother. 2005, 49:1465-1467.
37. Xiridou M., Borkent-Raven B., Hulshof J., Wallinga J. How hepatitis D virus can hinder the control of hepatitis B virus. PLoS ONE 2009, 4:4:e5247.